Johnson & Johnson [JNJ] is -4.86% lower this YTD. Is it still time to buy?

Johnson & Johnson [NYSE: JNJ] stock went on an upward path that rose over 0.25% on Monday, amounting to a one-week price increase of more than 2.46%.

Over the last 12 months, JNJ stock dropped by -9.96%. The one-year Johnson & Johnson stock forecast points to a potential upside of 13.19. The average equity rating for JNJ stock is currently 2.21, trading closer to a bullish pattern in the stock market.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The market cap for the stock reached $358.88 billion, with 2.41 billion shares outstanding and 2.40 billion shares in the current float. Compared to the average trading volume of 7.69M shares, JNJ stock reached a trading volume of 6902407 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Johnson & Johnson [JNJ]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for JNJ shares is $171.77 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on JNJ stock is a recommendation set at 2.21. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Goldman have made an estimate for Johnson & Johnson shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 30, 2024. The new note on the price target was released on April 18, 2024, representing the official price target for Johnson & Johnson stock. Previously, the target price had yet another drop from $170 to $163, while Wells Fargo kept a Equal Weight rating on JNJ stock. On December 01, 2023, analysts increased their price target for JNJ shares from 167 to 180.

The Average True Range (ATR) for Johnson & Johnson is set at 2.07, with the Price to Sales ratio for JNJ stock in the period of the last 12 months amounting to 4.00. The Price to Book ratio for the last quarter was 5.13, with the Price to Cash per share for the same quarter was set at 10.89. Price to Free Cash Flow for JNJ in the course of the last twelve months was 19.19 with Quick ratio for the last quarter at 0.94.

JNJ Stock Performance Analysis:

Johnson & Johnson [JNJ] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.46. With this latest performance, JNJ shares dropped by -2.85% in over the last four-week period, additionally sinking by -2.71% over the last 6 months – not to mention a drop of -9.96% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for JNJ stock in for the last two-week period is set at 55.80, with the RSI for the last a single of trading hit 63.61, and the three-weeks RSI is set at 51.97 for Johnson & Johnson [JNJ]. The present Moving Average for the last 50 days of trading for this stock 148.12, while it was recorded at 147.45 for the last single week of trading, and 154.44 for the last 200 days.

Insight into Johnson & Johnson Fundamentals:

Johnson & Johnson’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.94 and a Current Ratio set at 1.17.

JNJ Stock EPS

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for JNJ. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Johnson & Johnson go to 5.20%.

Johnson & Johnson [JNJ] Institutonal Ownership Details

The top three institutional holders of JNJ stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.4983%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $200.69 billion in JNJ stocks shares; and BERKSHIRE HATHAWAY INC, currently with $174.35 billion in JNJ stock with ownership which is approximately 5.8386%.

Most Popular